242 related articles for article (PubMed ID: 31608902)
1. A novel distyryl boron dipyrromethene with two functional tags for site-specific bioorthogonal photosensitisation towards targeted photodynamic therapy.
Guo X; Wong RCH; Zhou Y; Ng DKP; Lo PC
Chem Commun (Camb); 2019 Nov; 55(90):13518-13521. PubMed ID: 31608902
[TBL] [Abstract][Full Text] [Related]
2. A glutathione-responsive photosensitizer with fluorescence resonance energy transfer characteristics for imaging-guided targeting photodynamic therapy.
Cao JJ; Zhang MS; Li XQ; Yang DC; Xu G; Liu JY
Eur J Med Chem; 2020 May; 193():112203. PubMed ID: 32197150
[TBL] [Abstract][Full Text] [Related]
3. Targeted Delivery and Site-Specific Activation of β-Cyclodextrin-Conjugated Photosensitizers for Photodynamic Therapy through a Supramolecular Bio-orthogonal Approach.
Xue EY; Shi WJ; Fong WP; Ng DKP
J Med Chem; 2021 Oct; 64(20):15461-15476. PubMed ID: 34662121
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic treatment of melanoma cells using aza-dipyrromethenes as photosensitizers.
Castro KADF; Costa LD; Guieu S; Biazzotto JC; da Neves MGPMS; Faustino MAF; da Silva RS; Tomé AC
Photochem Photobiol Sci; 2020 Jul; 19(7):885-891. PubMed ID: 32662457
[TBL] [Abstract][Full Text] [Related]
5. Pyriplatin-Boron-Dipyrromethene Conjugates for Imaging and Mitochondria-Targeted Photodynamic Therapy.
Raza MK; Gautam S; Howlader P; Bhattacharyya A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Nov; 57(22):14374-14385. PubMed ID: 30376306
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
[TBL] [Abstract][Full Text] [Related]
7. A bioorthogonally activatable photosensitiser for site-specific photodynamic therapy.
Zhou Y; Wong RCH; Dai G; Ng DKP
Chem Commun (Camb); 2020 Jan; 56(7):1078-1081. PubMed ID: 31872834
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 17
Zhu W; Wang LX; Chen DY; Gao YH; Yan YJ; Wu XF; Wang M; Han YP; Chen ZL
Bioorg Med Chem Lett; 2018 Sep; 28(16):2784-2788. PubMed ID: 29279274
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeting BODIPY-loaded micelles as novel class of photosensitizer for photodynamic therapy.
Li M; Li X; Cao Z; Wu Y; Chen JA; Gao J; Wang Z; Guo W; Gu X
Eur J Med Chem; 2018 Sep; 157():599-609. PubMed ID: 30125721
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro photodynamic activities of folate-conjugated distyryl boron dipyrromethene based photosensitizers.
Ke MR; Yeung SL; Ng DK; Fong WP; Lo PC
J Med Chem; 2013 Nov; 56(21):8475-83. PubMed ID: 24088087
[TBL] [Abstract][Full Text] [Related]
11. Novel BODIPY-based nano-biomaterials with enhanced D-A-D structure for NIR-triggered photodynamic and photothermal therapy.
Chen G; Xiong M; Jiang C; Zhao Y; Chen L; Ju Y; Jiang J; Xu Z; Pan J; Li X; Wang K
Bioorg Chem; 2024 Jul; 148():107494. PubMed ID: 38797067
[TBL] [Abstract][Full Text] [Related]
12. Highly Phototoxic Transplatin-Modified Distyryl-BODIPY Photosensitizers for Photodynamic Therapy.
Padrutt R; Babu V; Klingler S; Kalt M; Schumer F; Anania MI; Schneider L; Spingler B
ChemMedChem; 2021 Feb; 16(4):694-701. PubMed ID: 33164336
[TBL] [Abstract][Full Text] [Related]
13. Trifluoromethyl Boron Dipyrromethene Derivatives as Potential Photosensitizers for Photodynamic Therapy.
Liu JY; Zhou PZ; Ma JL; Jia X
Molecules; 2018 Feb; 23(2):. PubMed ID: 29463048
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy.
Lim SH; Thivierge C; Nowak-Sliwinska P; Han J; van den Bergh H; Wagnières G; Burgess K; Lee HB
J Med Chem; 2010 Apr; 53(7):2865-74. PubMed ID: 20199028
[TBL] [Abstract][Full Text] [Related]
15. BODIPY-vinyl dibromides as triplet sensitisers for photodynamic therapy and triplet-triplet annihilation upconversion.
Dartar S; Ucuncu M; Karakus E; Hou Y; Zhao J; Emrullahoglu M
Chem Commun (Camb); 2021 Jun; 57(49):6039-6042. PubMed ID: 34037007
[TBL] [Abstract][Full Text] [Related]
16. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
[TBL] [Abstract][Full Text] [Related]
17. BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT.
Bhattacharyya A; Jameei A; Karande AA; Chakravarty AR
Eur J Med Chem; 2021 Aug; 220():113438. PubMed ID: 33915370
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.
Karaman O; Almammadov T; Emre Gedik M; Gunaydin G; Kolemen S; Gunbas G
ChemMedChem; 2019 Nov; 14(22):1879-1886. PubMed ID: 31663667
[TBL] [Abstract][Full Text] [Related]
19. Construction of cathepsin B-responsive fluorescent probe and photosensitizer using a ferrocenyl boron dipyrromethene dark quencher.
Wang Q; Yu L; Wong RCH; Lo PC
Eur J Med Chem; 2019 Oct; 179():828-836. PubMed ID: 31295715
[TBL] [Abstract][Full Text] [Related]
20. Preparation of unsymmetrical distyryl BODIPY derivatives and effects of the styryl substituents on their in vitro photodynamic properties.
He H; Lo PC; Yeung SL; Fong WP; Ng DK
Chem Commun (Camb); 2011 Apr; 47(16):4748-50. PubMed ID: 21409245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
